118 related articles for article (PubMed ID: 24854104)
1. The novel HDAC inhibitor OBP-801/YM753 enhances the effects of 5-fluorouracil with radiation on esophageal squamous carcinoma cells.
Furutani A; Sowa Y; Fujiwara H; Otsuji E; Sakai T
Oncol Res; 2014; 21(5):281-6. PubMed ID: 24854104
[TBL] [Abstract][Full Text] [Related]
2. ERRATUM.
Furutani A; Sowa Y; Fujiwara H; Otsuji E; Sakai T
Oncol Res; 2016 Jan; 23(1):87. PubMed ID: 29021025
[TBL] [Abstract][Full Text] [Related]
3. Combination of a novel HDAC inhibitor OBP-801/YM753 and a PI3K inhibitor LY294002 synergistically induces apoptosis in human endometrial carcinoma cells due to increase of Bim with accumulation of ROS.
Yoshioka T; Yogosawa S; Yamada T; Kitawaki J; Sakai T
Gynecol Oncol; 2013 May; 129(2):425-32. PubMed ID: 23403163
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
5. Metformin-induced alterations in nucleotide metabolism cause 5-fluorouracil resistance but gemcitabine susceptibility in oesophageal squamous cell carcinoma.
Mynhardt C; Damelin LH; Jivan R; Peres J; Prince S; Veale RB; Mavri-Damelin D
J Cell Biochem; 2018 Jan; 119(1):1193-1203. PubMed ID: 28722177
[TBL] [Abstract][Full Text] [Related]
6. Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models.
Hou W; Qin X; Zhu X; Fei M; Liu P; Liu L; Moon H; Zhang P; Greshock J; Bachman KE; Ye BC; Wang H; Zang CY
Oncol Rep; 2013 Aug; 30(2):707-14. PubMed ID: 23708506
[TBL] [Abstract][Full Text] [Related]
7. Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells.
Liu Y; Wang X; Wang Y; Zhang Y; Zheng K; Yan H; Zhang L; Chen W; Wang X; Liu Q; Wang S; Wang Y
Int J Oncol; 2015 Jan; 46(1):299-307. PubMed ID: 25333998
[TBL] [Abstract][Full Text] [Related]
8. A COX-2 inhibitor enhances the antitumor effects of chemotherapy and radiotherapy for esophageal squamous cell carcinoma.
Yusup G; Akutsu Y; Mutallip M; Qin W; Hu X; Komatsu-Akimoto A; Hoshino I; Hanari N; Mori M; Akanuma N; Isozaki Y; Matsubara H
Int J Oncol; 2014 Apr; 44(4):1146-52. PubMed ID: 24535229
[TBL] [Abstract][Full Text] [Related]
9. Three Combined Treatments, a Novel HDAC Inhibitor OBP-801/YM753, 5-Fluorouracil, and Paclitaxel, Induce G₂ Phase Arrest Through the p38 Pathway in Human Ovarian Cancer Cells.
Akiyama M; Sowa Y; Taniguchi T; Watanabe M; Yogosawa S; Kitawaki J; Sakai T
Oncol Res; 2017 Sep; 25(8):1245-1252. PubMed ID: 28117030
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells.
Lee JH; Park JH; Jung Y; Kim JH; Jong HS; Kim TY; Bang YJ
Mol Cancer Ther; 2006 Dec; 5(12):3085-95. PubMed ID: 17172411
[TBL] [Abstract][Full Text] [Related]
11. Differentiation-inducing factor-1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and thymidylate synthase mRNAs accumulation.
Sprio AE; Di Scipio F; Ceppi P; Salamone P; Di Carlo F; Scagliotti GV; Papotti M; Ceccarelli A; Berta GN
Cancer Chemother Pharmacol; 2012 Apr; 69(4):983-9. PubMed ID: 22139443
[TBL] [Abstract][Full Text] [Related]
12. Association between radiation dose and pathological complete response after preoperative radiochemotherapy in esophageal squamous cell cancer.
Ordu AD; Nieder C; Geinitz H; Scherer V; Kup PG; Schuster T; Combs SE; Fakhrian K
Anticancer Res; 2014 Dec; 34(12):7255-61. PubMed ID: 25503157
[TBL] [Abstract][Full Text] [Related]
13. Effects of carbon-ion radiotherapy combined with a novel histone deacetylase inhibitor, cyclic hydroxamic-acid-containing peptide 31 in human esophageal squamous cell carcinoma.
Kano M; Yamada S; Hoshino I; Murakami K; Akutsu Y; Sakata H; Nishimori T; Usui A; Miyazawa Y; Kamada T; Tsujii H; Matsubara H
Anticancer Res; 2009 Nov; 29(11):4433-8. PubMed ID: 20032389
[TBL] [Abstract][Full Text] [Related]
14. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
[TBL] [Abstract][Full Text] [Related]
15. Cooperative inhibitory effect of sinomenine combined with 5-fluorouracil on esophageal carcinoma.
Wang J; Yang ZR; Dong WG; Zhang JX; Guo XF; Song J; Qiu S
World J Gastroenterol; 2013 Dec; 19(45):8292-300. PubMed ID: 24363520
[TBL] [Abstract][Full Text] [Related]
16. A novel HDAC inhibitor OBP-801 and a PI3K inhibitor LY294002 synergistically induce apoptosis via the suppression of survivin and XIAP in renal cell carcinoma.
Yamada T; Horinaka M; Shinnoh M; Yoshioka T; Miki T; Sakai T
Int J Oncol; 2013 Oct; 43(4):1080-6. PubMed ID: 23900601
[TBL] [Abstract][Full Text] [Related]
17. 5-Fluorouracil up-regulates interferon pathway gene expression in esophageal cancer cells.
Matsumura Y; Yashiro M; Ohira M; Tabuchi H; Hirakawa K
Anticancer Res; 2005; 25(5):3271-8. PubMed ID: 16101138
[TBL] [Abstract][Full Text] [Related]
18. [A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
Sasaki T; Nakamura K; Toba T; Kimura M; Ohga S; Urashima Y; Terashima H; Masuda K
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1417-20. PubMed ID: 12214470
[TBL] [Abstract][Full Text] [Related]
19. YM753, a novel histone deacetylase inhibitor, exhibits antitumor activity with selective, sustained accumulation of acetylated histones in tumors in the WiDr xenograft model.
Shindoh N; Mori M; Terada Y; Oda K; Amino N; Kita A; Taniguchi M; Sohda KY; Nagai K; Sowa Y; Masuoka Y; Orita M; Sasamata M; Matsushime H; Furuichi K; Sakai T
Int J Oncol; 2008 Mar; 32(3):545-55. PubMed ID: 18292931
[TBL] [Abstract][Full Text] [Related]
20. Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.
Okada K; Hakata S; Terashima J; Gamou T; Habano W; Ozawa S
Oncol Rep; 2016 Oct; 36(4):1875-85. PubMed ID: 27509880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]